Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose A Karam

Showing results (1-10 of 261) with videos related to

Pageof 27
Sort By:
The Journal of Urology|March 21, 2018
Editorial CommentJose A Karam
BJU International|March 5, 2011
Editorial comment: Improved cancer specific-survival in patients with carcinoma invading bladder muscle expressing cyclo-oxygenase-2Jose A Karam
International Journal of Urology : Official Journal of the Japanese Urological Association|May 7, 2014
Editorial Comment to Growing teratoma syndrome: clinical and radiographic characteristicsDae Y Kim, Jose A Karam
European Urology|February 8, 2011
The dark side of targeted therapyJose A Karam, Christopher G Wood
The Journal of Urology|December 20, 2011
Editorial commentPatrick A Kenney, Jose A Karam
European Urology|March 14, 2012
The effects of temporary ischemia in partial nephrectomy on renal functional outcomes: how can effects best be estimated, and can they be mitigated?Jose A Karam, Christopher G Wood
The Journal of Urology|January 20, 2010
Editorial commentJose A Karam, Christopher G Wood
European Urology|February 27, 2013
Words of wisdom: re: prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trialsJose A Karam, Christopher G Wood
The Lancet. Oncology|April 1, 2008
Minimally invasive radical cystectomy for bladder cancer?Jose A Karam, Arthur I Sagalowsky
F1000 Medicine Reports|October 16, 2010
Optimal timing of chemotherapy and cystectomyJose A Karam, Ashish M Kamat
Pageof 27

Showing results (1-10 of 261) with videos related to

Sort By:
Pageof 27
The Journal of Urology|March 21, 2018
Editorial CommentJose A Karam
BJU International|March 5, 2011
Editorial comment: Improved cancer specific-survival in patients with carcinoma invading bladder muscle expressing cyclo-oxygenase-2Jose A Karam
International Journal of Urology : Official Journal of the Japanese Urological Association|May 7, 2014
Editorial Comment to Growing teratoma syndrome: clinical and radiographic characteristicsDae Y Kim, Jose A Karam
European Urology|February 8, 2011
The dark side of targeted therapyJose A Karam, Christopher G Wood
The Journal of Urology|December 20, 2011
Editorial commentPatrick A Kenney, Jose A Karam
European Urology|March 14, 2012
The effects of temporary ischemia in partial nephrectomy on renal functional outcomes: how can effects best be estimated, and can they be mitigated?Jose A Karam, Christopher G Wood
The Journal of Urology|January 20, 2010
Editorial commentJose A Karam, Christopher G Wood
European Urology|February 27, 2013
Words of wisdom: re: prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trialsJose A Karam, Christopher G Wood
The Lancet. Oncology|April 1, 2008
Minimally invasive radical cystectomy for bladder cancer?Jose A Karam, Arthur I Sagalowsky
F1000 Medicine Reports|October 16, 2010
Optimal timing of chemotherapy and cystectomyJose A Karam, Ashish M Kamat
Pageof 27